Contact area, cortical bone density, and area changes were measured along the entire length of the prosthesis.
However, it does experience cancellous bone density and architectural changes with age [ 16, 17], ligament injury [ 35, 41] knee replacement [ 42] and osteoarthritis [ 34, 71].
An imbalance between these parameters leads to decreased bone density and osteoporosis; these changes may affect the role of bone marrow as a homing site for DTC.
The ovariectomized, nontreated rats showed vacuolation in the bone marrow, reduced marrow and osteogenic activity, complete absence of osteoblasts, reduced bone density, and marked degenerative changes, while the group treated with estrogen showed an increase in bone formation with minimal marrow activity and osteoblast entrapment at the margins.
Osteoporosis is a bone disease that combines both a decrease in bone density and its internal architecture changes.
This manifests clinically as swelling, erythema, and pain, and can progress to decreased bone density and obvious joint architecture changes.
Analysis of the changes in bone density and sex steroid concentrations showed a closer relationship between the changes in BMD and serum estradiol than with serum testosterone.
Simultaneously, mechanisms that modulate bone density and microstructure can cause significant changes in the bone at a certain level, leaving the remaining bone length unaffected.
A prospective observational study was performed to investigate possible changes in blood lead concentrations at multiple intervals during lactation for 6 months postpartum and to relate changes in blood lead concentrations to changes in bone density and other variables.
